Skip to main content
HR 789 114th Congress House

Tick-Borne Disease Research Accountability and Transparency Act of 2015

Official title: To provide for research with respect to Lyme disease and other tick-borne diseases, and for other purposes.

Introduced: February 11, 2015 See on congress.gov
Health Advisory bodiesCongressional oversightDepartment of Health and Human ServicesExecutive agency funding and structure
More subjectsShow fewer subjects
Health programs administration and fundingInfectious and parasitic diseasesInsectsMedical researchResearch administration and funding
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 6, 2015
Referred to the Subcommittee on Health.
Feb 5, 2015
Referred to the House Committee on Energy and Commerce.
Feb 5, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 6, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Tick-Borne Disease Research Accountability and Transparency Act of 2015

Amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to conduct or support epidemiological, basic, translational, and clinical research regarding Lyme disease and other tick-borne diseases.

Directs HHS to establish the Interagency Lyme and Tick-Borne Disease Working Group to review all HHS efforts concerning tick-borne diseases to ensure interagency coordination and examine research priorities. Requires the Working Group to: (1) provide a summary of tick-borne disease research, advances, and scientific viewpoints every two years; (2) make recommendations to HHS regarding tick-borne disease activities; and (3) hold annual public meetings.

Requires HHS to submit a strategic plan for tick-borne disease research within three years of enactment and every five years thereafter that includes: (1) budgetary requirements; (2) benchmarks for improving tick-borne disease diagnosis, treatment, outcomes, and prevention; and (3) a plan to disseminate Working Group summaries and other relevant information on tick-borne disease to health professionals and the public.
 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 789: Tick-Borne Disease Research Accountability and Transparency Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-789/
MLA
"H.R. 789: Tick-Borne Disease Research Accountability and Transparency Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-789/.
Bluebook (legal)
H.R. 789, 114th Cong. (2026), https://openamerica.io/bill/114-HR-789/.
Markdown link
[H.R. 789: Tick-Borne Disease Research Accountability and Transparency Act of 2015](https://openamerica.io/bill/114-HR-789/)
Report a problem